Literature DB >> 3213608

Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females.

R R Recker1, D B Kimmel, A M Parfitt, K M Davies, N Keshawarz, S Hinders.   

Abstract

Transilial bone biopsies were obtained from 34 healthy postmenopausal women following in vivo fluorochrome labeling. Stained and unstained undecalcified sections were evaluated using a Merz grid. Standard histomorphometric data from cancellous bone tissue were collected and the results were evaluated and presented as variables commonly used in bone histomorphometry. The normal ranges, medians, means, and standard deviations for the group of 34 are presented in tabular form for structural, surface, basic dynamic, and derived dynamic data. Similar data for individuals grouped by ages 45-54, 55-64, and 65-74 are also presented. Secular trends for the whole group are evaluated. The structural and surface data are not much different from previous reports of sudden-death accident victims, when methodologic differences are considered. The mineral apposition rate (MAR) was 0.53 +/- 0.08 micron/day, similar to previous reports in cancellous bone, but one-third less than in cortical bone. MAR showed a marked decline with age. In contrast, the extent of tetracycline-labeled surfaces varied widely without a secular trend. Double-label surface (dLS/BS) ranged from 0.5 to 8.0% and single-label surface (sLS/BS), from 0.5 to 10.5%. Mineralizing osteoid surface (MS/OS) varied from 2 to 64%. Using only double-label surface to represent mineralizing surface, volume-based bone formation rate (BFR/BV) ranged from 0.7 to 28%/yr, and the remodeling period (Rm.P) varied from 0.28 to 4.5 years. Calculations using other representations of mineralizing surface [double plus one-half single label (MS/BS"); all label (MS/BS')] are also presented. These bone histomorphometric data are important because: (1) they come from a cohort of living subjects that was recruited solely for the purpose of establishing normal bone histomorphometry; (2) they represent the age range of patients with postmenopausal osteoporosis; and (3) they markedly expand the bone histomorphometric database of healthy persons given in vivo fluorochrome labeling prior to transilial biopsy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3213608     DOI: 10.1002/jbmr.5650030203

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  56 in total

1.  Osteocyte viability with glucocorticoid treatment: relation to histomorphometry.

Authors:  P N Sambrook; D R Hughes; A E Nelson; B G Robinson; R S Mason
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

2.  Bone matrix mineralization is preserved during early perimenopausal stage in healthy women: a paired biopsy study.

Authors:  B M Misof; P Roschger; S Blouin; R Recker; K Klaushofer
Journal:  Osteoporos Int       Date:  2015-12-09       Impact factor: 4.507

3.  Bone adaptation in osteoporosis.

Authors:  Mei-Shu Shih
Journal:  Curr Osteoporos Rep       Date:  2012-09       Impact factor: 5.096

4.  Trabecular bone histomorphometry in humans with Type 1 Diabetes Mellitus.

Authors:  Laura A G Armas; Mohammed P Akhter; Andjela Drincic; Robert R Recker
Journal:  Bone       Date:  2011-10-07       Impact factor: 4.398

5.  Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria.

Authors:  J E Zerwekh; K Sakhaee; N A Breslau; F Gottschalk; C Y Pak
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

6.  Bone biopsy and densitometry findings in a child with Camurati-Engelmann disease.

Authors:  Jonas Bondestam; Mervi K Mäyränpää; Shiro Ikegawa; Eino Marttinen; Heikki Kröger; Outi Mäkitie
Journal:  Clin Rheumatol       Date:  2007-01-06       Impact factor: 2.980

7.  Pelvic insufficiency fracture associated with severe suppression of bone turnover by alendronate therapy.

Authors:  Kazuhiro Imai; Seizo Yamamoto; Yorito Anamizu; Toshiyuki Horiuchi
Journal:  J Bone Miner Metab       Date:  2007-08-25       Impact factor: 2.626

Review 8.  Issues in modern bone histomorphometry.

Authors:  R R Recker; D B Kimmel; D Dempster; R S Weinstein; T J Wronski; D B Burr
Journal:  Bone       Date:  2011-07-23       Impact factor: 4.398

9.  Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings.

Authors:  Inari S Tamminen; Helena Valta; Hannu Jalanko; Sari Salminen; Mervi K Mäyränpää; Hanna Isaksson; Heikki Kröger; Outi Mäkitie
Journal:  Pediatr Nephrol       Date:  2014-02-23       Impact factor: 3.714

10.  PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; James Sliney; Hua Zhou; Thomas L Nickolas; Emily M Stein; Elzbieta Dworakowski; Maryann Dellabadia; Rebecca Ives; Donald J McMahon; Chiyuan Zhang; Shonni J Silverberg; Elizabeth Shane; Serge Cremers; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.